What type of study is this?

This is a Cohort Study study (also classified as: Human Clinical Trial).

December 8, 2025BloodOpen Access

Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden

View Full Paper

Ask AI

Bookmark

Authors

Retrospective analysis reveals improved overall survival in non-erythrodermic mycosis fungoides compared to classic Sézary syndrome.

Survival rates indicate non-erythrodermic patients show 100% 2-year overall survival compared to 74% in classic cases.
Demographics revealed no significant age or race differences, yet 76.2% of neSS patients were female.
ECP stands out as the most utilized first-line treatment for non-erythrodermic patients.
Further exploration is needed to understand treatment differences and clinical outcomes in cutaneous T-cell lymphoma.

Thomas et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark